Erica Reed

584 total citations
28 papers, 400 citations indexed

About

Erica Reed is a scholar working on Infectious Diseases, Epidemiology and Applied Microbiology and Biotechnology. According to data from OpenAlex, Erica Reed has authored 28 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 12 papers in Epidemiology and 9 papers in Applied Microbiology and Biotechnology. Recurrent topics in Erica Reed's work include Antibiotic Use and Resistance (9 papers), Bacterial Identification and Susceptibility Testing (6 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Erica Reed is often cited by papers focused on Antibiotic Use and Resistance (9 papers), Bacterial Identification and Susceptibility Testing (6 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Erica Reed collaborates with scholars based in United States. Erica Reed's co-authors include Kurt Stevenson, Debra A. Goff, Karri A. Bauer, Jessica E. West, Julie E. Mangino, Preeti Pancholi, Eric Wenzler, Allison Wehr, Joan-Miquel Balada-Llasat and Zeinab El Boghdadly and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Erica Reed

26 papers receiving 394 citations

Peers

Erica Reed
Reham Kaki Saudi Arabia
David X. Li United States
M. Cecilia Di Pentima United States
Sarah J. Janelle United States
Jaye Weston United States
Eimear Brannigan United Kingdom
Reham Kaki Saudi Arabia
Erica Reed
Citations per year, relative to Erica Reed Erica Reed (= 1×) peers Reham Kaki

Countries citing papers authored by Erica Reed

Since Specialization
Citations

This map shows the geographic impact of Erica Reed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erica Reed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erica Reed more than expected).

Fields of papers citing papers by Erica Reed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erica Reed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erica Reed. The network helps show where Erica Reed may publish in the future.

Co-authorship network of co-authors of Erica Reed

This figure shows the co-authorship network connecting the top 25 collaborators of Erica Reed. A scholar is included among the top collaborators of Erica Reed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erica Reed. Erica Reed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reed, Erica, et al.. (2025). Fluconazole step-down therapy versus echinocandins for the treatment of Candida glabrata invasive candidiasis with candidaemia. Journal of Antimicrobial Chemotherapy. 80(4). 996–1000. 2 indexed citations
2.
Lustberg, Mark, Melissa D. Gordon, Nicholas Kman, et al.. (2024). Clinical outcomes in patients with mild to moderate coronavirus disease 2019 treated with monoclonal antibody therapy versus an untreated control cohort. Antiviral Therapy. 29(4). 221990454–221990454.
3.
Gerlach, Anthony T., Steven W. Cotten, Bruce Doepker, et al.. (2023). Development of 8‐h urine collections and an augmented renal clearance dosing program at an academic medical center. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 6(10). 1132–1138. 3 indexed citations
4.
Malvestutto, Carlos, Nicholas Kman, Mark Lustberg, et al.. (2022). Evidence Based Scarce Resource Allocation During the COVID-19 Pandemic: A Case Study of Bamlanivimab Administration in the Emergency Department. Hospital Pharmacy. 57(5). 639–645. 1 indexed citations
5.
Smith, Jessica M., et al.. (2021). Predictors of respiratory bacterial co-infection in hospitalized COVID-19 patients. Diagnostic Microbiology and Infectious Disease. 102(1). 115558–115558. 12 indexed citations
6.
Boghdadly, Zeinab El, et al.. (2021). Oral fluoroquinolones for definitive treatment of gram-negative bacteremia in cancer patients. Supportive Care in Cancer. 29(9). 5057–5064. 7 indexed citations
7.
Reed, Erica, et al.. (2021). Clinical Outcomes of Daptomycin Versus Anti-Staphylococcal Beta-Lactams in Definitive Treatment of Methicillin-susceptible Staphylococcus aureus Bloodstream Infections. International Journal of Antimicrobial Agents. 58(2). 106363–106363. 6 indexed citations
8.
Mollenkopf, Dixie F., Erica Reed, Kurt Stevenson, et al.. (2021). Implementation of an antimicrobial stewardship program in a veterinary medical teaching institution. Journal of the American Veterinary Medical Association. 258(2). 170–178. 18 indexed citations
9.
Reed, Erica, et al.. (2021). Effectiveness of fidaxomicin versus oral vancomycin in the treatment of recurrent clostridioides difficile. Journal of Clinical Pharmacy and Therapeutics. 46(4). 993–998. 8 indexed citations
10.
Reed, Erica, et al.. (2020). Effectiveness of short vs long‐course perioperative antibiotics in lung transplant recipients with donor positive respiratory cultures. Transplant Infectious Disease. 23(3). e13518–e13518. 6 indexed citations
11.
Stevenson, Kurt, et al.. (2018). Clinical Outcomes with Penicillin Versus Alternative β‐Lactams in the Treatment of Penicillin‐Susceptible Staphylococcus aureus Bacteremia. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 38(7). 769–775. 12 indexed citations
12.
Theodoropoulos, Nicole, et al.. (2016). Safety and Efficacy of Fecal Microbiota Transplants for the Treatment of Clostridium difficile at a Tertiary Care Academic Medical Center. Open Forum Infectious Diseases. 3(suppl_1). 1 indexed citations
13.
Reed, Erica, Mark Lustberg, Kurt Stevenson, et al.. (2016). Antimicrobial Use for Febrile Neutropenia in Patients with Hematologic Malignancies Undergoing Autologous Hematopoietic Stem Cell Transplant and Clinical Outcome. Biology of Blood and Marrow Transplantation. 22(3). S158–S158. 1 indexed citations
14.
Wenzler, Eric, Debra A. Goff, Julie E. Mangino, et al.. (2015). Impact of rapid identification of Acinetobacter Baumannii via matrix-assisted laser desorption ionization time-of-flight mass spectrometry combined with antimicrobial stewardship in patients with pneumonia and/or bacteremia. Diagnostic Microbiology and Infectious Disease. 84(1). 63–68. 47 indexed citations
15.
Porter, Kyle, et al.. (2015). An evaluation of acuity adjustment metrics to track medication expense over time. American Journal of Health-System Pharmacy. 72(24). 2157–2165. 2 indexed citations
17.
Reed, Erica, Jessica E. West, Preeti Pancholi, et al.. (2013). Improving the management of candidemia through antimicrobial stewardship interventions. Diagnostic Microbiology and Infectious Disease. 78(2). 157–161. 53 indexed citations
18.
Reed, Erica, Kurt Stevenson, Jessica E. West, Karri A. Bauer, & Debra A. Goff. (2013). Impact of formulary restriction with prior authorization by an antimicrobial stewardship program. Virulence. 4(2). 158–162. 41 indexed citations
19.
Goff, Debra A., et al.. (2012). Is the "Low-Hanging Fruit" Worth Picking for Antimicrobial Stewardship Programs?. Clinical Infectious Diseases. 55(4). 587–592. 77 indexed citations
20.
Bazan, José A., Karri A. Bauer, Alan S. Hollister, et al.. (2010). Peramivir Pharmacokinetics in Two Critically Ill Adults with 2009 H1N1 Influenza A Concurrently Receiving Continuous Renal Replacement Therapy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 30(10). 1016–1020. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026